Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras (CBRS) shares fell 19% in three months due to profitability concerns, margin compression, and customer concentration risks. However, the company benefits from a strong $25.4B RPO, expanding manufacturing capacity, and improving earnings estimates. Wall Street's consensus price target suggests 56.93% upside, but near-term margin recovery and broader customer diversification remain key concerns. The stock holds a Zacks Rank #3 (Hold) rating.